Literature DB >> 34331768

Reduced infiltration of regulatory T cells in tumours from mice fed daily with gamma-tocotrienol supplementation.

Shonia Subramaniam1,2, Jeya Seela Anandha Rao3, Premdass Ramdas4, Mei Han Ng5, Methil Kannan Kutty6, Kanga Rani Selvaduray2, Ammu Kutty Radhakrishnan3,7.   

Abstract

Gamma-tocotrienol (γT3) is an analogue of vitamin E with beneficial effects on the immune system, including immune-modulatory properties. This study reports the immune-modulatory effects of daily supplementation of γT3 on host T helper (Th) and T regulatory cell (Treg ) populations in a syngeneic mouse model of breast cancer. Female BALB/c mice were fed with either γT3 or vehicle (soy oil) for 2 weeks via oral gavage before they were inoculated with syngeneic 4T1 mouse mammary cancer cells (4T1 cells). Supplementation continued until the mice were euthanized. Mice (n = 6) were euthanized at specified time-points for various analysis (blood leucocyte, cytokine production and immunohistochemistry). Tumour volume was measured once every 7 days. Gene expression studies were carried out on tumour-specific T lymphocytes isolated from splenic cultures. Supplementation with γT3 increased CD4+ (p < 0.05), CD8+ (p < 0.05) T-cells and natural killer cells (p < 0.05) but suppressed Treg cells (p < 0.05) in peripheral blood when compared to animals fed with the vehicle. Higher interferon (IFN)-γ and lower transforming growth factor (TGF)-ꞵ levels were noted in the γT3 fed mice. Immunohistochemistry findings revealed higher infiltration of CD4+ cells, increased expression of interleukin-12 receptor-beta-2 (IL-12ꞵ2R), interleukin (IL)-24 and reduced expression of cells that express the forkhead box P3 (FoxP3) in tumours from the γT3-fed animals. Gene expression studies showed the down-regulation of seven prominent genes in splenic CD4+ T cells isolated from γT3-fed mice. Supplementation with γT3 from palm oil-induced T cell-dependent cell-mediated immune responses and suppressed T cells in the tumour microenvironment in a syngeneic mouse model of breast cancer.
© 2021 British Society for Immunology.

Entities:  

Keywords:  T lymphocyte; adaptive immunity; breast cancer; gamma-tocotrienol; mouse model

Mesh:

Substances:

Year:  2021        PMID: 34331768      PMCID: PMC8506134          DOI: 10.1111/cei.13650

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  47 in total

1.  Toll-like receptors control activation of adaptive immune responses.

Authors:  M Schnare; G M Barton; A C Holt; K Takeda; S Akira; R Medzhitov
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

2.  The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages.

Authors:  Shanjin Cao; Jianguo Liu; Lihua Song; Xiaojing Ma
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

Review 3.  Th17: an effector CD4 T cell lineage with regulatory T cell ties.

Authors:  Casey T Weaver; Laurie E Harrington; Paul R Mangan; Maya Gavrieli; Kenneth M Murphy
Journal:  Immunity       Date:  2006-06       Impact factor: 31.745

4.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

5.  Palm tocotrienols inhibit proliferation of murine mammary cancer cells and induce expression of interleukin-24 mRNA.

Authors:  Kanga Rani Selvaduray; Ammu K Radhakrishnan; Methil Kannan Kutty; Kalanithi Nesaretnam
Journal:  J Interferon Cytokine Res       Date:  2010-12       Impact factor: 2.607

Review 6.  Regulatory T cells in cancer.

Authors:  Marc Beyer; Joachim L Schultze
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

7.  Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.

Authors:  Huan Yang; Huiqin Zhou; Ping Feng; Xiaoni Zhou; Huiyan Wen; Xiaofang Xie; Haiying Shen; Xueming Zhu
Journal:  J Exp Clin Cancer Res       Date:  2010-07-10

8.  Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.

Authors:  Mohamed R Akl; Nehad M Ayoub; Bilal S Abuasal; Amal Kaddoumi; Paul W Sylvester
Journal:  Fitoterapia       Date:  2012-12-22       Impact factor: 2.882

9.  The molecular basis of JAK/STAT inhibition by SOCS1.

Authors:  Nicholas P D Liau; Artem Laktyushin; Isabelle S Lucet; James M Murphy; Shenggen Yao; Eden Whitlock; Kimberley Callaghan; Nicos A Nicola; Nadia J Kershaw; Jeffrey J Babon
Journal:  Nat Commun       Date:  2018-04-19       Impact factor: 14.919

10.  Reduced infiltration of regulatory T cells in tumours from mice fed daily with gamma-tocotrienol supplementation.

Authors:  Shonia Subramaniam; Jeya Seela Anandha Rao; Premdass Ramdas; Mei Han Ng; Methil Kannan Kutty; Kanga Rani Selvaduray; Ammu Kutty Radhakrishnan
Journal:  Clin Exp Immunol       Date:  2021-08-18       Impact factor: 4.330

View more
  2 in total

1.  Gamma-tocotrienol modifies methylation of HOXA10, IRF4 and RORα genes in CD4+ T-lymphocytes: Evidence from a syngeneic mouse model of breast cancer.

Authors:  Ammu K Radhakrishnan; Jeya Seela Anandha Rao; Shonia Subramaniam; Premdass Ramdas
Journal:  Curr Res Immunol       Date:  2021-10-09

2.  Reduced infiltration of regulatory T cells in tumours from mice fed daily with gamma-tocotrienol supplementation.

Authors:  Shonia Subramaniam; Jeya Seela Anandha Rao; Premdass Ramdas; Mei Han Ng; Methil Kannan Kutty; Kanga Rani Selvaduray; Ammu Kutty Radhakrishnan
Journal:  Clin Exp Immunol       Date:  2021-08-18       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.